In a controlled, double blind study, the smoking of a single cigarette has been shown to increase the platelet's response to a standard aggregating stimulus. This phenomenon appears to be specifically related to the inhaling of tobacco smoke; it does not follow the smoking of lettuce leaf filled cigarettes. The platelet effect seems independent of the rise in plasma free fatty acids which follows cigarette smoking. Smoking-induced potentiation of platelet aggregation may help to explain the increased incidence of arterial thrombi and/or atheromatous plaques in cigarette smokers. 
Myocardial infarction,2 occlusive peripheral arterial disease,3 and late occlusion of aortofemoral bypass grafts4 are examples of this phenomenon. Because the blood platelet appears to play the central role in the initiation of arterial thrombi,5 definition of the relationship between smoking and platelet function seems important.
The lifespan of platelets has been found to be reduced during periods of heavy smoking.6 Platelet adhesiveness has been measured in cigarette smokers,7 and conflicting results have emerged. In two independent studies,8 9 platelet aggregation was chronically increased in heavy smokers when compared with a population of non-smokers. Acute effects of smoking on the electrophoretic mobility of platelets was suggested in one of these studies,9 but no acute effect on platelet aggregation could be shown in either study. That any of the above changes in platelet function are a result of some constituent of tobacco smoke remains unproven. A possible specific effect of smoking on platelet aggregation is the subject of this paper.
The measurement of platelet aggregation in vivo suffers from lack of reproducibility. Several contributing factors have now been identified. 1 Disodium ADP was dissolved in veronal buffer (pH 7.35) to a concentration of 10 mg % adjusted to pH 6.8, and frozen in aliquots at -40(C. For each subject, a dose of ADP was chosen which would just produce a small reversible primary wave of aggregation, and this dose was then used throughout. The range in ADP concentration for this effect was between 1.3 and 2.6x10-6M. It was hoped that this relatively small ADP stimulus would unmask pre-existing qualitative platelet changes, and would also be closer to "physiologic" levels of aggregating stimuli.
Other parameters measured on each sample included: platelet count, platelet factor 3 release by the method of Zucker and Peterson,17 and plasma free fatty acids (FFA) by the method of Dole. '8 Twenty seven healthy male and female volunteers were requested to abstain from all medications for 10 days and from all caloric intake and cigarette smoking for at least 12 hours prior to study. Each subiect was placed in a reclining chair, and a #19 butterfly-type needle inserted into the largest antecubital vein. A slow infusion of physiologic saline was begun to keep the needle patent. This avoided the stress of recurrent venepuncture. Following 30 to 60 min rest, blood samples were drawn every 10 min via the butterfly needle, using a two syringe technique. The first several blood samples were discarded, until the subject appeared to be "comfortable" with the protocol. The total blood drawn during the entire study was between 250 and 300 ml per patient.
After several baseline measurements were obtained, the subject smoked a single cigarette, and another series of studies were done at 10 min intervals. After a period of 30 to 60 min, a second cigarette was smoked and a third series of studies performed. One of the cigarettes was a standard commercial filtered brand, containing 1.3 mg nicotine. The other was a filtered cigarette in which lettuce leaf was substituted for tobacco;19 these cigarettes have no nicotine content. To preclude observer bias, those performing and calculating the platelet aggregation studies were not told which samples were pre or post smoking or which cigarette had been used. To minimize artifacts due to ageing of platelet samples, all studies were performed in a rigid time-controlled manner, and were completed within a maximum of 30 min from time of blood drawing.
Results
Serial Studies. figure 1 .
Aoute Effects in Smokers: Tobacco. On the same day, similar studies were performed in the same 11 subjects before and after smoking the standard cigarette, under the same experimental conditions. Results are shown in the final column of figure 1 . Using the t-test for paired data, the increased aggregation seen following standard smoking was compared to the change in aggregation from lettuce leaf cigarette smoking. The difference was significant at the P <.01 level. To determine whether prior exposure to lettuce leaf smoking had "sensi- (w Wtized" the patient to the second cigarette, the order of testing was reversed in 3 subjects. The results were unchanged; increased aggregation response followed the standard cigarette only.
Timing of Response. Serial measurements ( fig. 2 ) showed no increase in aggregation immediately following cigarette smoking. Increase in aggregation was maximum at 10 and 20 min, and at or near baseline by 30 min. Two patterns were noted. The commonest ( fig. 2, top line) was an increase in primary wave, with loss of complete disaggregation. Less often, the primary wave was of sufficient magnitude to result in a release reaction, with a secondary wave of aggregation resulting ( fig. 2,  bottom line) .
Free Fatty Acids. None of the above subjects developed an increase in FFA after the lettuce leaf cigarette. After the standard cigarette, all eleven developed increased FFA. The mean rise was 134 mg% from a mean baseline level of 556 mg%. The time of maximal free fatty acid rise was 30 min after smoking. The degree of increment for individual subjects did not correlate with the degree of enhancement of aggregation. In three subjects, the rise in FFA occurred only after the increase in aggregation was noted. 22 We had expected that the free fatty acids would in turn be responsible for the observed increase in platelet aggregability, but our data did not suggest this.
The enhancement of platelet aggregation observed after smoking could be a direct effect of nicotine, or could be due to the known increase in plasma catecholamines.20 (We were unable to measure plasma epinephrine levels in parallel with platelet function in this study, because of the large volumes of blood which such determinations would have required.) Catecholamines may play a major role in the in vivo platelet aggregation response. Epinephrine is a well-studied stimulus of platelet aggregation and the release reaction.23 24 Moreover, the addition of epinephrine to platelets in vivo has recently been shown to enhance their subsequent response to ADP-induced aggregation. 25 Cigarette smokers have an increased risk of myocardial infarction26 as well as sudden death.2 In experimental animals also, in vivo induction of platelet aggregates can lead to both myocardial infarction and sudden death.27 If a single cigarette can sensitize blood platelets to ADP, such platelets would hypothetically be more ready to participate in platelet plug formation, leading to vascular occlusion.
The data presented here suggest a possible direct causative link between cigarette smoking and arterial thrombotic disease. Moreoever, there is literature2'31 which suggests that the encrustation of layers of platelets on the arterial wall, at sites of turbulent blood flow and/or endothelial damage, may be the precursor of the atherosclerotic plaque. If this literature has any validity, the results of the present study may also help to explain the mechanism by which smoking may accelerate atherosclerosis. These considerations lend added importance to the development and study of agents which can effectively modify platelet reactions.
